4
Changes in Ownership
RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001104659-25-100851
Chief Technical Officer sold 14,437 shares at an average $112.03 ($1,617,337)
- Chief Technical Officer acquired 14,437 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Shulman Joseph Chief Technical Officer | 2025-10-16 | Option exercise 10b5-1 | +2,093 | $27.35 | $57,244 | 10,602 | D |
| Shulman Joseph Chief Technical Officer | 2025-10-16 | Option exercise 10b5-1 | +12,344 | $30.66 | $378,467 | 22,946 | D |
| Shulman Joseph Chief Technical Officer | 2025-10-16 | Sale 10b5-1 | −2,693 | $110.95 | $298,784 | 20,253 | D |
| Shulman Joseph Chief Technical Officer | 2025-10-16 | Sale 10b5-1 | −8,332 | $112.06 | $933,646 | 11,921 | D |
| Shulman Joseph Chief Technical Officer | 2025-10-16 | Sale 10b5-1 | −3,412 | $112.81 | $384,908 | 8,509 | D |
| Derivatives | |||||||
| Shulman Joseph Chief Technical Officer | 2025-10-16 | Option exercise · Stock Options (Right to Buy) 10b5-1 | −2,093 | 14,657 | D | ||
| Shulman Joseph Chief Technical Officer | 2025-10-16 | Option exercise · Stock Options (Right to Buy) 10b5-1 | −12,344 | 10,469 | D | ||
| Open-market sales · 14,437 sh · avg $112.03 · $1,617,337 | |||||||
Loading xslF345X05/tm2529018-1_4seq1.xml…